Medicare Enrolled
Dr. Sanjiv Parikh, M.D.
Optician · Clifton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parikh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parikh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parikh
Dr. Sanjiv Parikh is an optician specialist in Clifton, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Parikh performed 8,758 Medicare services across 2,313 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parikh received a total of $3,508 from 28 pharmaceutical and/or device companies across 169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parikh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in NJ
$3,508 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,758
Medicare services
Top 6% in NJ for optician
2,313
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~461 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
2,249 | $0 | $89 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,882 | $78 | $416 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
703 | $1 | $82 |
| Joint lubricant injection (Synvisc) | 624 | $7 | $300 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
609 | $0 | $10 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
286 | $0 | $50 |
| Contrast dye for imaging, lower concentration | 251 | $0 | $100 |
| Injection, methylprednisolone acetate, 40 mg | 231 | $6 | $40 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
202 | $62 | $874 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
199 | $106 | $1,710 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
197 | $9 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
195 | $110 | $529 |
| Electrocardiogram, 1 to 3 leads A test that records the electrical activity of the heart using one to three electrodes placed on the body. |
144 | $6 | $125 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
130 | $12 | $200 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
120 | $5 | $40 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
96 | $225 | $11,688 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
88 | $101 | $9,784 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
76 | $233 | $37,103 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
70 | $120 | $27,700 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
52 | $21 | $75 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $50 | $381 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
46 | $95 | $560 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $141 | $746 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
44 | $237 | $8,900 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
33 | $50 | $2,000 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
27 | $286 | $15,704 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
24 | $237 | $32,946 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
23 | $117 | $22,630 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
23 | $553 | $29,043 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
22 | $169 | $10,975 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
19 | $8 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.3% high complexity
64.3% medium
32.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,508
Total received (2018-2024)
Avg $501/year across 7 years
Top 24% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
169
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,487 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$497
2023
$1,143
2022
$204
2021
$588
2020
$423
2019
$171
2018
$481
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$164
Collegium Pharmaceutical, Inc.
$147
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$80
PROTEGA PHARMACEUTIALS INC
$41
DePuy Synthes Sales Inc.
$35
Azurity Pharmaceuticals, Inc.
$16
VERTEX PHARMACEUTICALS INCORPORATED
$15
Top 3 companies account for 78.6% of 2024 payments
All-time payments by company (2018-2024) ›
Pacira Pharmaceuticals Incorporated
$659
Collegium Pharmaceutical, Inc.
$617
Boston Scientific Corporation
$448
Horizon Therapeutics plc
$202
Medtronic, Inc.
$164
Inari Medical, Inc.
$157
Pernix Therapeutics Holdings, Inc.
$124
PROTEGA PHARMACEUTIALS INC
$123
Daiichi Sankyo Inc.
$122
Almatica Pharma LLC
$100
PFIZER INC.
$95
SCILEX PHARMACEUTICALS INC.
$86
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$80
DePuy Synthes Sales Inc.
$78
Kowa Pharmaceuticals America, Inc.
$69
Scilex Pharmaceuticals Inc.
$67
IBSA Pharma Inc.
$50
Allergan Inc.
$43
Medtronic USA, Inc.
$38
Azurity Pharmaceuticals, Inc.
$32
Axonics, Inc.
$30
Horizon Pharma plc
$29
Hikma Pharmaceuticals USA
$21
SANOFI-AVENTIS U.S. LLC
$18
VERTEX PHARMACEUTICALS INCORPORATED
$15
TerSera Therapeutics LLC
$14
RedHill Biopharma Inc.
$13
Purdue Pharma L.P.
$12
Top 3 companies account for 49.2% of all-time payments
Associated products mentioned in payments ›
Axonics · BOTOX THERAPEUTIC · DUEXIS · FlowTriever · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GRALISE · HORIZANT · Horizant · INTELLIS ADAPTIVESTIM · Iovera · Kloxxado · LYRICA · Licart · MONOVISC · Morphabond ER · Movantik · NAPRELAN · ORTHOVISC · PENNSAID · QMIIZ ODT · RAYOS · RELISTOR · ROXYBOND · SEGLENTIS · SPECTRA WAVEWRITER · SYMPROIC · SYNVISC-ONE · Seglentis · VECTRIS · WATCHMAN FLX · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
13,892
Per 100K population
2680.4
County median income
$87,137
Nearest hospital
ST MARY'S GENERAL HOSPITAL
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parikh is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NJ), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parikh experienced with bupivacaine injection, 0.5 mg?
Based on Medicare claims data, Dr. Parikh performed 2,249 bupivacaine injection, 0.5 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parikh receive payments from pharmaceutical companies?
Yes. Dr. Parikh received a total of $3,508 from 28 companies across 169 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parikh's costs compare to other opticians in Clifton?
Dr. Parikh's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parikh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Clifton
Browse opticians in Clifton ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Pacira Pharmaceuticals Incorporated Payments to Doctors
See all physicians who received payments from Pacira Pharmaceuticals Incorporated.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology